Axon Enterprise, Inc $AXON Position Lifted by Allworth Financial LP

Allworth Financial LP raised its stake in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 8,015.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 504,079 shares of the biotechnology company’s stock after acquiring an additional 497,868 shares during the period. Axon Enterprise comprises about 0.7% of Allworth Financial LP’s investment portfolio, making the stock its 21st largest position. Allworth Financial LP’s holdings in Axon Enterprise were worth $212,983,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently bought and sold shares of AXON. Keel Point LLC lifted its holdings in shares of Axon Enterprise by 4.4% during the first quarter. Keel Point LLC now owns 599 shares of the biotechnology company’s stock valued at $254,000 after acquiring an additional 25 shares during the period. Bridgewater Advisors Inc. boosted its stake in shares of Axon Enterprise by 4.4% in the 2nd quarter. Bridgewater Advisors Inc. now owns 616 shares of the biotechnology company’s stock valued at $352,000 after purchasing an additional 26 shares in the last quarter. Pinnacle Wealth Planning Services Inc. boosted its stake in shares of Axon Enterprise by 7.8% in the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 361 shares of the biotechnology company’s stock valued at $153,000 after purchasing an additional 26 shares in the last quarter. 44 Wealth Management LLC grew its holdings in shares of Axon Enterprise by 6.0% in the 1st quarter. 44 Wealth Management LLC now owns 530 shares of the biotechnology company’s stock worth $225,000 after purchasing an additional 30 shares during the last quarter. Finally, Owl Creek Wealth Partners LLC grew its holdings in shares of Axon Enterprise by 84.8% in the 2nd quarter. Owl Creek Wealth Partners LLC now owns 85 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 39 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Down 2.6%

Shares of Axon Enterprise stock opened at $307.11 on Friday. Axon Enterprise, Inc has a 12 month low of $291.45 and a 12 month high of $665.07. The company has a quick ratio of 2.60, a current ratio of 3.00 and a debt-to-equity ratio of 0.76. The stock has a market cap of $25.01 billion, a PE ratio of 98.43, a price-to-earnings-growth ratio of 5.99 and a beta of 1.48. The business has a fifty day simple moving average of $422.24 and a 200 day simple moving average of $469.16.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). The company had revenue of $908.55 million for the quarter, compared to analyst estimates of $934.33 million. Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The company’s revenue was up 27.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.17 earnings per share. Research analysts predict that Axon Enterprise, Inc will post 2.10 EPS for the current year.

Axon Enterprise News Summary

These are some of the AXON news items that stood out recently:

  • Positive Sentiment: Maryland’s Howard County Police Department adopted Axon’s drone-as-first-responder solutions, including Skydio X10 drones, counter-drone technology and AI tools. The deployment supports Axon’s public-safety technology demand, though no contract value was disclosed. Article: Axon Air Drone as First Responder Program Soars into Howard County, Maryland
  • Negative Sentiment: Axon’s third-quarter adjusted EPS was reported below consensus, and revenue of $908.55 million also trailed estimates of $934.33 million. Revenue nevertheless grew 27.8% year over year. The earnings shortfall is a key reason for the shares’ recent weakness; Barclays has also lowered its expectations for the stock. Article: Levi & Korsinsky Investigation Notice Article: Barclays Lowers Expectations for Axon
  • Negative Sentiment: Two law firms publicized investigations into potential securities-law claims related to Axon’s earnings report. These are allegations under investigation, not findings of wrongdoing, but add legal uncertainty and could keep investor attention on the earnings miss. Article: SBS Law Fraud Investigation Notice

Insider Buying and Selling at Axon Enterprise

In other news, insider Isaiah Fields sold 1,017 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the transaction, the insider directly owned 56,264 shares of the company’s stock, valued at $27,032,038.80. This trade represents a 1.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the business’s stock in a transaction on Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the sale, the president directly owned 296,974 shares in the company, valued at approximately $170,590,774.82. This represents a 5.35% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 37,397 shares of company stock valued at $21,234,034 over the last quarter. Insiders own 4.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on AXON. Barclays cut their price target on shares of Axon Enterprise from $688.00 to $507.00 and set an “overweight” rating for the company in a report on Monday. UBS Group upped their price objective on shares of Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Northcoast Research raised their price objective on shares of Axon Enterprise from $650.00 to $680.00 and gave the stock a “buy” rating in a report on Tuesday, August 11th. Citigroup reiterated a “market outperform” rating on shares of Axon Enterprise in a research note on Monday, November 2nd. Finally, Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 3rd. Thirteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $612.18.

View Our Latest Stock Report on AXON

About Axon Enterprise

(Free Report)

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

Further Reading

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.